Paper30416846
Iron and magnetic: new research direction of the ferroptosis-based cancer therapy.
Wang S and 11 others. Am J Cancer Res, 2018. Cited by 102 papers, by iCite.
Cite this record
ConductScience Library. Iron and magnetic: new research direction of the ferroptosis-based cancer therapy. Papers, record 30416846. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30416846
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References80
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28223795 | Nanoparticle-based hyperthermia distinctly impacts production of ROS, expression of Ki-67, TOP2A, and TPX2, and induction of apoptosis in pancreatic cancer. | Int J Nanomedicine | 2017 | https://conductscience.org/library/papers/28223795 | PubMed |
| 2 | 27514700 | Ferroptosis is an autophagic cell death process. | Cell Res | 2016 | https://conductscience.org/library/papers/27514700 | PubMed |
| 3 | 18355723 | Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. | Chem Biol | 2008 | https://conductscience.org/library/papers/18355723 | PubMed |
| 4 | 27287467 | Iron Oxide Nanoparticles Induce Autophagosome Accumulation through Multiple Mechanisms: Lysosome Impairment, Mitochondrial Damage, and ER Stress. | Mol Pharm | 2016 | https://conductscience.org/library/papers/27287467 | PubMed |
| 5 | 15456710 | Microenvironmental and cellular consequences of altered blood flow in tumours. | Br J Radiol | 2003 | https://conductscience.org/library/papers/15456710 | PubMed |
| 6 | 23102669 | MicroRNA and cancer. | Mol Oncol | 2012 | https://conductscience.org/library/papers/23102669 | PubMed |
| 7 | 16278235 | Targeted disruption of hepatic frataxin expression causes impaired mitochondrial function, decreased life span and tumor growth in mice. | Hum Mol Genet | 2005 | https://conductscience.org/library/papers/16278235 | PubMed |
| 8 | 25728673 | HSPB1 as a novel regulator of ferroptotic cancer cell death. | Oncogene | 2015 | https://conductscience.org/library/papers/25728673 | PubMed |
| 9 | 28453245 | External Magnetic Field-Enhanced Chemo-Photothermal Combination Tumor Therapy via Iron Oxide Nanoparticles. | ACS Appl Mater Interfaces | 2017 | https://conductscience.org/library/papers/28453245 | PubMed |
| 10 | 18678913 | Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/18678913 | PubMed |
| 11 | 26403645 | Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. | Hepatology | 2016 | https://conductscience.org/library/papers/26403645 | PubMed |
| 12 | 25236395 | Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. | Cell Death Differ | 2015 | https://conductscience.org/library/papers/25236395 | PubMed |
| 13 | 27184711 | Physical, Chemical, and Biological Structures based on ROS-Sensitive Moieties that are Able to Respond to Oxidative Microenvironments. | Adv Mater | 2016 | https://conductscience.org/library/papers/27184711 | PubMed |
| 14 | 26379789 | Targeted Mesoporous Iron Oxide Nanoparticles-Encapsulated Perfluorohexane and a Hydrophobic Drug for Deep Tumor Penetration and Therapy. | Theranostics | 2015 | https://conductscience.org/library/papers/26379789 | PubMed |
| 15 | 27668796 | Ultrasmall nanoparticles induce ferroptosis in nutrient-deprived cancer cells and suppress tumour growth. | Nat Nanotechnol | 2016 | https://conductscience.org/library/papers/27668796 | PubMed |
| 16 | 27441659 | Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells. | Cell Death Dis | 2016 | https://conductscience.org/library/papers/27441659 | PubMed |
| 17 | 23740388 | Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes. | Chem Soc Rev | 2013 | https://conductscience.org/library/papers/23740388 | PubMed |
| 18 | 9708920 | Increased flux of free radicals in cells subjected to hyperthermia: detection by electron paramagnetic resonance spin trapping. | FEBS Lett | 1998 | https://conductscience.org/library/papers/9708920 | PubMed |
| 19 | 23620667 | Targeted therapy for human hepatic carcinoma cells using folate-functionalized polymeric micelles loaded with superparamagnetic iron oxide and sorafenib in vitro. | Int J Nanomedicine | 2013 | https://conductscience.org/library/papers/23620667 | PubMed |
| 20 | 15516961 | Why do cancers have high aerobic glycolysis? | Nat Rev Cancer | 2004 | https://conductscience.org/library/papers/15516961 | PubMed |
Cited by79
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 102 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42978988 | Magnetic nanoplatforms at the tumor redox interface: from catalytic ROS amplification to ferroptosis and multimodal cancer therapy. | Front Oncol | 2026 | https://conductscience.org/library/papers/42978988 | PubMed |
| 42825017 | Ferroptosis in metabolic dysfunction-associated steatotic liver disease. | Front Immunol | 2026 | https://conductscience.org/library/papers/42825017 | PubMed |
| 42803694 | Gestational Changes in Placental Iron Homeostasis are Associated With Ferroptosis-Associated Redox Signaling and Trophoblast Behavior. | FASEB J | 2026 | https://conductscience.org/library/papers/42803694 | PubMed |
| 42776293 | The SLC7A11 Thermostat: A Molecular Signaling Switch Between Ferroptosis and Disulfidptosis in Neurodegenerative Disease. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42776293 | PubMed |
| 42750945 | Pulsed electromagnetic fields induce ferroptosis in osteosarcoma cells and promote osteogenic differentiation. | J Bone Oncol | 2026 | https://conductscience.org/library/papers/42750945 | PubMed |
| 42471540 | Mitochondrial Communication Networks in the Bone Microenvironment: From the Maintenance of Homeostasis to Translational Interventions for Bone Diseases. | Stem Cell Rev Rep | 2026 | https://conductscience.org/library/papers/42471540 | PubMed |
| 42232184 | Natural products in treating sepsis-associated lung and liver injuries by mediating ferroptosis, current progress, and future perspective. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42232184 | PubMed |
| 41938712 | Crosstalk between autophagy and ferroptosis in diabetes. | Genes Dis | 2026 | https://conductscience.org/library/papers/41938712 | PubMed |
| 41625218 | Spin Relaxation Does Not Preclude Magnetic Field Effects on Lipid Autoxidation. | ACS Cent Sci | 2026 | https://conductscience.org/library/papers/41625218 | PubMed |
| 41088176 | The multiplex crosstalk between non-coding RNAs, programmed cell death and related mechanisms: a dynamic duo in hematological malignancies. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/41088176 | PubMed |
| 41019823 | Enhanced Hydrophilicity and Antifouling Performance of PEG with Sulfoxide-Containing Side Chains for Nanomedicine Applications. | Polym Sci Technol | 2025 | https://conductscience.org/library/papers/41019823 | PubMed |
| 40892292 | Huangqi Guizhi Wuwu Decoction inhibits ferroptosis to improve cyclophosphamide induced immunosuppression through regulation of arachidonic acid metabolism. | J Mol Histol | 2025 | https://conductscience.org/library/papers/40892292 | PubMed |
| 40439806 | Mechanism and role of ferroptosis in the development of gastric cancer. | Clin Exp Med | 2025 | https://conductscience.org/library/papers/40439806 | PubMed |
| 40311754 | Electromagnetic fields regulate iron metabolism: From mechanisms to applications. | J Adv Res | 2026 | https://conductscience.org/library/papers/40311754 | PubMed |
| 40192984 | A causal inference study exploring the impact of iron status on the risk of thyroid cancer based on two-sample mendelian randomization. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40192984 | PubMed |
| 40115032 | Targeting regulated cell death: Apoptosis, necroptosis, pyroptosis, ferroptosis, and cuproptosis in anticancer immunity. | J Transl Int Med | 2025 | https://conductscience.org/library/papers/40115032 | PubMed |
| 40098803 | Inhibitory Effects of Paclitaxel-Loaded Iron Oxide Nanoparticles on Non-Small Cell Lung Cancer by Enhancing Autophagy-Dependent Ferroptosis and Apoptosis Pathways. | Cancer Manag Res | 2025 | https://conductscience.org/library/papers/40098803 | PubMed |
| 40018650 | Application of Nanomaterials in Early Imaging and Advanced Treatment of Atherosclerosis. | Chem Biomed Imaging | 2025 | https://conductscience.org/library/papers/40018650 | PubMed |
| 39411064 | Ferroptosis and myocardial ischemia-reperfusion: mechanistic insights and new therapeutic perspectives. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39411064 | PubMed |
| 39380574 | Exploring the Use of Intracellular Chelation and Non-Iron Metals to Program Ferroptosis for Anticancer Application. | Inorganics (Basel) | 2024 | https://conductscience.org/library/papers/39380574 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30416846
GET https://conductscience.org/api/papers/v1/30416846/references?page=2